Robert R Dufresne

Title: The Innovations of Robert R. Dufresne

Introduction

Robert R. Dufresne is an accomplished inventor based in Wellesley, MA (US). He has made significant contributions to the field of antiviral research, particularly through his innovative work on peptide inhibitors. His dedication to advancing medical science is evident in his patented inventions.

Latest Patents

Dufresne holds a patent for "Long lasting fusion peptide inhibitors of viral infection." This patent focuses on peptides that exhibit anti-viral and anti-fusogenic activity. The modified peptides are designed to provide greater stability and improved half-life in vivo. Notably, the selected peptides include fusion inhibitors DP178 and DP107, along with related peptides and analogs. These modified peptides are capable of forming covalent bonds with one or more blood components, preferably a mobile blood component.

Career Highlights

Dufresne's career is marked by his role at Conjuchem, Inc., where he has been instrumental in developing innovative solutions for viral infections. His work has contributed to the understanding and treatment of viral diseases, showcasing his commitment to improving public health.

Collaborations

Dufresne has collaborated with notable colleagues, including Dominique P. Bridon and Nissab Boudjellab. These partnerships have further enhanced his research and development efforts in the field of antiviral therapies.

Conclusion

Robert R. Dufresne's contributions to antiviral research through his patented innovations highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in the treatment of viral infections.